Congress and the Institute for Legal Reform (ILR) is urging the American Bar Association and state bar associations to help crack down on attorney ads regarding suits against drug companies and medical devices.
The effort to curb lawsuits against pharmaceutical companies and medical device producers recently gained the support of Rep. Bob Goodlatte (R-VA), who is the House Judiciary Committee chair. Goodlatte sent out over 50 letters to bar associations -- including to the State Bar of Texas -- asking for their help in reining in these types of suits. He also sent out a letter targeting groups responsible for airing the plaintiffs’ attorney ads.
In the letter, Goodlatte cites the American Medical Association’s recent stance on the ads due to their concern that patients might stop taking their medications without seeking medical advice.
Despite a 2014 Harvard study that revealed that prescription drugs are a major health concern and rank fourth along with stroke as a leading cause of death in the U.S., the ILR is holding its ground against the lawsuit ads.
“Pharmaceutical ads go through careful FDA scrutiny,” ILR President Lisa Rickard said. “Ads for lawsuits against drug makers should as well.”